Patents by Inventor Richard B. Patchett

Richard B. Patchett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADRB2 GENE POLYMORPHISM ASSOCIATED WITH INTRAOCULAR PRESSURE RESPONSE TO TOPICAL BETA-BLOCKERS
    Publication number: 20110251195
    Abstract: The invention provides a single nucleotide polymorphism (SNP) rs1042714 in the human ADRB2 gene (Gln27Glu) associated with a clinically meaningful reduction in intraocular pressure (IOP) in a human following treatment with a topical beta-blocker. Nucleic acids comprising the SNP are used to screen glaucoma-afflicted individuals to thereby provide an improved method for genotype-based prescribing of beta-blockers in glaucoma management.
    Type: Application
    Filed: June 23, 2011
    Publication date: October 13, 2011
    Applicant: Marshfield Clinic
    Inventors: Catherine Anne McCarty, James K. Burmester, Bickol N. Mukesh, Richard B. Patchett, Russell Alan Wilke
  • ADRB2 GENE POLYMORPHISM ASSOCIATED WITH INTRAOCULAR PRESSURE RESPONSE TO TOPICAL BETA-BLOCKERS
    Publication number: 20090298839
    Abstract: The invention provides a single nucleotide polymorphism (SNP) rs1042714 in the human ADRB2 gene (Gln27Glu) associated with a clinically meaningful reduction in intraocular pressure (IOP) in a human following treatment with a topical beta-blocker. Nucleic acids comprising the SNP are used to screen glaucoma-afflicted individuals to thereby provide an improved method for genotype-based prescribing of beta-blockers in glaucoma management.
    Type: Application
    Filed: May 29, 2009
    Publication date: December 3, 2009
    Inventors: Catherine Anne McCarty, James K. Burmester, Bickol N. Mukesh, Richard B. Patchett, Russell Alan Wilke